4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kuros Biosciences AG (KURN) operates in the Medical Devices industry and is headquartered in Schlieren, Switzerland with about 178 employees. Its market capitalization is roughly $869 million. In the fiscal year ended 2025-12-31, KURN reported $146M in revenue and $3M in net income.
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $146M | $85M | $34M | $18M | — |
| Gross Profit | $129M | $70M | $24M | $11M | — |
| Operating Income (EBIT) | $9M | ($6M) | ($10M) | ($13M) | — |
| Net Income | $3M | ($5M) | ($10M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $134M | $93M | $72M | $83M | — |
| Total Liabilities | $49M | $28M | $15M | $14M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KURN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms